Amina Sadiq

Gujrat, PB 50700, Pakistan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Dual-acting flavonol analogues as cholinesterase inhibitors and anticonvulsant agents: integrated in vitro, in vivo, and in silico studies.

Dual-acting flavonol analogues as cholinesterase inhibitors and anticonvulsant agents: integrated in vitro, in vivo, and in silico studies.

Journal: RSC advances
Published: July 25, 2026

The Staudinger reaction: a versatile synthetic tool for the construction of β-lactams, heterocycles, and functional organic molecules.

The Staudinger reaction: a versatile synthetic tool for the construction of β-lactams, heterocycles, and functional organic molecules.

Journal: RSC advances
Published: July 09, 2026

Discovery of 4-aminochalcone-based dual α-glucosidase and aldose reductase inhibitors: in vitro, in vivo, and in silico studies.

Discovery of 4-aminochalcone-based dual α-glucosidase and aldose reductase inhibitors: in vitro, in vivo, and in silico studies.

Journal: RSC advances
Published: June 26, 2026

Synthesis and evaluation of vanillin-based sulfonates as potent α-glucosidase inhibitors through in vitro, in vivo, and in silico approaches.

Synthesis and evaluation of vanillin-based sulfonates as potent α-glucosidase inhibitors through in vitro, in vivo, and in silico approaches.

Journal: Scientific reports
Published: April 11, 2026

Chalcone-sulfonate ester derivatives as dual urease and α-amylase inhibitors: synthesis, biological evaluation and integrated computational studies.

Chalcone-sulfonate ester derivatives as dual urease and α-amylase inhibitors: synthesis, biological evaluation and integrated computational studies.

Journal: RSC advances
Published: March 29, 2026

Development of coumarin-sulfonate scaffolds for cholinesterase inhibition: experimental and computational studies toward Alzheimer's disease therapy.

Development of coumarin-sulfonate scaffolds for cholinesterase inhibition: experimental and computational studies toward Alzheimer's disease therapy.

Journal: RSC advances
Published: March 27, 2026

Coumarin hybrids as privileged therapeutic scaffolds: biological activities, mechanistic insights, and therapeutic potential.

Coumarin hybrids as privileged therapeutic scaffolds: biological activities, mechanistic insights, and therapeutic potential.

Journal: RSC advances
Published: February 23, 2026

Behavioral and biomarker assessment of flavonols as multifunctional neuroprotective nootropic agents.

Behavioral and biomarker assessment of flavonols as multifunctional neuroprotective nootropic agents.

Journal: Future medicinal chemistry
Published: February 09, 2026

Triphenylene as a versatile scaffold for advanced functional materials.

Triphenylene as a versatile scaffold for advanced functional materials.

Journal: RSC advances
Published: November 14, 2025

Aurone-based α-glucosidase inhibitors for antidiabetic therapy: in vitro, in vivo, and in silico studies.

Aurone-based α-glucosidase inhibitors for antidiabetic therapy: in vitro, in vivo, and in silico studies.

Journal: Future medicinal chemistry
Published: November 12, 2025

Thioflavonols as potent α-glucosidase inhibitors: in vitro, in vivo, and computational analysis.

Thioflavonols as potent α-glucosidase inhibitors: in vitro, in vivo, and computational analysis.

Journal: Future medicinal chemistry
Published: October 21, 2025

Flavonols as potent inhibitors of tyrosinase & pancreatic lipase: synthesis, docking, MD simulation, DFT, and ADMET.

Flavonols as potent inhibitors of tyrosinase & pancreatic lipase: synthesis, docking, MD simulation, DFT, and ADMET.

Journal: Future medicinal chemistry
Published: August 28, 2025
Showing 1-12 of 45

Last Updated: 09/26/2026